Bristol Myers BMY recently secured a meaningful label expansion for Sotyktu, with the FDA approving the drug for adults with ...

Delivering the keynote address, Prof. Ajay Sood, Principal Scientific Advisor (PSA) to the Government of India, underscored the urgency of breaking silos across health systems.

McKenzie Law Firm announces Amari Bailey as the 2025 Teen Drinking and Driving Prevention PSA Scholarship winner, ...

The FDA will review the supplemental Biologics License Application for tildrakizumab for the treatment of adults with active PsA.

Early intensive treatment for PsA with csDMARDs or 6 months of TNFi is superior to standard step-up care, and better outcomes ...

Oral TYK2 inhibitor deucravacitinib receives FDA approval for active psoriatic arthritis based on significantly improved ACR20 response rates.

Researchers have discovered immune cells that escape inflamed skin, travel through the blood, and help spark psoriatic arthritis once they reach vulnerable joints. Credit Shutterstock Scientists have ...

Psoriatic arthritis is an autoimmune condition that causes joint inflammation, skin symptoms, and pain. People searching for psoriatic arthritis prescriptions are often looking for detailed ...

At the recent Maui Derm, George Martin, MD, founder and program director of the meeting, shared major developments in therapeutics for psoriatic disease -- particularly in the oral space. From ...

IsoPSA test analyzes prostate cancer-specific structural variants of PSA protein to aid biopsy decisions in men over 50 with elevated PSA levels. The FDA approved IsoPSA based on a large-scale, ...